Searchable abstracts of presentations at key conferences in endocrinology

ea0020p23 | Adrenal | ECE2009

IL-6 and osteoprotogerin levels in subjects with non-functioning adrenal adenomas

Yener Serkan , Comlekci Abdurrahman , Yuksel Faize , Comlekci Abdurrahman , Akinci Baris , Demir Tevfik , Yesil Sena

Data regarding cardiovascular risk in subjects with non-functioning adrenal adenoma is limited. The aim of this study is to investigate osteoprotogerin (OPG) and Interleukin-6 (IL-6) levels in subjects with non functioning adrenal incidentalomas.Of 51 subjects without findings of hypercortisolism or other adrenal gland disorders (AI), 32 BMI-unmatched controls (C) and 20 BMI-matched controls (BC) were enrolled. Participants underwent hormonal evaluation ...

ea0020p102 | Thyroid | ECE2009

Levothyroxine suppression treatment for benign thyroid nodules alters coagulation

Demir Tevfik , Akinci Baris , Comlekci Abdurrahman , Karaoglu Oguzhan , Ozcan Mehmet Ali , Yener Serkan , Yuksel Faize , Secil Mustafa , Yesil Sena

Objective: Endogenous hyperthyroidism is associated with altered coagulation. The aim of the present study is to investigate the effect of levothyroxine (LT4) suppression treatment for benign thyroid nodules on coagulation system.Design: Prospective case-control study.Patients: Thirty consecutive euthyroid pre-menopausal women with nodular goitre disease and 28 healthy controls were included in the study.Meas...

ea0016p794 | Thyroid | ECE2008

Decreased fibrinolytic activity due to levothyroxine suppression therapy for benign thyroid nodules

Demir Tevfik , Akinci Baris , Comlekci Abdurrahman , Karaoglu Oguzhan , Yener Serkan , Ozcan Mehmet Ali , Yuksel Faize , Secil Mustafa , Yesil Sena

Thyroid dysfunction is associated with altered levels of several coagulation factors. The aim of this study is to investigate the effect of levothyroxine suppression therapy for benign thyroid nodules on coagulation system.Thirty-six patients with benign thyroid nodules, who were applicant for levothyroxine suppression therapy, were included in the study. Thirty patients completed 1 year follow-up period. Levothyroxine was given to maintain TSH level bet...